GGrantIndex
Sort

11,323 grants matching glioblastoma

Advanced Perfusion MRI of Treatment Response and Progression in Glioblastoma

$229,500
Alexey Samsonov · University Of Wisconsin-Madison · R21 · FY2015 · EB

Receptor Tyrosine Kinase/PTEN Interactions in Gliomas

$229,425
Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2004 · NS

Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma

$229,400
Courtney A Miller · University Of Florida · R61 · FY2022 · NS

EBV BASED STRATEGIES FOR AIDS RELATED MALIGNANCIES

$229,200
University Of North Carolina Chapel Hill · R01 · FY2002 · CA

Alternative splicing regulation of caspase-2 gene

$229,190
Jane Y Wu · Northwestern University At Chicago · R01 · FY2008 · GM

Alternative splicing regulation of caspase-2 gene

$229,190
Jane Y Wu · Northwestern University At Chicago · R01 · FY2007 · GM

Exploring the Therapeutic Potential of Stem Cell Biology in Gliomas

$229,124
Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Rare Central Nervous System Cancers Initiative

$229,124
Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Identifying New Glioma-Associated Tumor Suppressors and Oncogenes

$229,124
Mark Gilbert · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Ferroptosis sensitization in glioblastoma

$229,078
Dominique Higgins · Univ Of North Carolina Chapel Hill · K01 · FY2025 · NS

Serum exosome diagnosis for glioma

$229,042
Xandra Owens Breakefield · Massachusetts General Hospital · R21 · FY2009 · CA

ENHANCING GLIOMA IMMUNOTHERAPY WITH TEMODAR-INDUCED LYMPHOPENIA AND A MULTIVALENT

$228,970
John H Sampson · Duke University · P50 · FY2011 · NS

Clinical Trials and Imaging Core

$228,964
Annick Desjardins · Duke University · P01 · FY2022 · CA

Administrative Core

$228,864
Jann N Sarkaria · Mayo Clinic Rochester · U19 · FY2023 · CA

Targeting SREBP-1 regulated fatty acid synthesis pathway to treat glioblastoma

$228,750
Deliang Guo · Ohio State University · R21 · FY2012 · NS

MOUSE MODELS FOR EXPLORING THE DEVELOPMENTAL ORIGINS OF SEX DIFFERENCES IN GLIOBLASTOMA

$228,750
Joshua B Rubin · Washington University · R21 · FY2017 · NS

Regulation of the Tumor Immune Cell Landscape by Ciliated Glioblastoma Cells

$228,750
Matthew Robert Sarkisian · University Of Florida · R21 · FY2023 · NS

Slow cycling cell RNA based T cell therapy to prevent recurrence in GBM

$228,750
Loic Pierre Deleyrolle · University Of Florida · R21 · FY2022 · NS

Research Training Program in Neuro-Oncology

$228,437
Brian Patrick O'Neill · Mayo Clinic Rochester · T32 · FY2011 · NS

CLINICAL TRIALS IN USE OF PHOTODYNAMIC THERAPY FOR SUPRAFRONTAL BRAIN TUMORS

$228,401
Healthone Alliance · P01 · FY2001 · CA

MECHANISMS OF PDT INDUCED AND INHERENT RESISTANCE

$228,401
Healthone Alliance · P01 · FY2002 · CA

CLINICAL TRIALS IN USE OF PHOTODYNAMIC THERAPY FOR SUPRAFRONTAL BRAIN TUMORS

$228,401
Healthone Alliance · P01 · FY2002 · CA

MECHANISMS OF PDT INDUCED AND INHERENT RESISTANCE

$228,401
Healthone Alliance · P01 · FY2001 · CA

Photodynamic Priming for Bidirectional Modulation of Drug Transport Across the Blood-Brain Tumor Barrier

$228,335
Huang Chiao Huang · Univ Of Maryland, College Park · R21 · FY2021 · EB

Targeting the PI3K Pathway in Malignant Glioma

$228,190
W K Alfred Yung · University Of Tx Md Anderson Can Ctr · P50 · FY2016 · CA